Retrovirus protease characterized as a dimeric aspartic proteinase (original) (raw)

Abstract

Retroviruses and retroviruslike elements have a protease for specific cleavage of their polyprotein precursors. On the basis of amino acid sequences conserved among species and the sensitivity to protease inhibitors, it was proposed that the retrovirus protease could be classified as an aspartic proteinase. Since the virus protease molecule is comparable to a single domain of aspartic proteinases having two symmetrical domains, we hypothesized and examined the dimer formation of the protease. The results of biochemical molecular mass determination and cross-linking experiments demonstrated that the virus protease molecules self-assemble into dimers. An inhibitory effect of fragmented protease molecules suggests the possibility that the intermolecular association is required for their activity. Other experiments of chemical inactivation suggest a close resemblance of the catalytic features of retrovirus and aspartic proteinases. Characterizations of these bovine and avian virus proteases would provide basic knowledge for the design of retrovirus protease-specific inhibitors, which is one of the possible strategies against human immunodeficiency virus infection.

2226

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams S. E., Mellor J., Gull K., Sim R. B., Tuite M. F., Kingsman S. M., Kingsman A. J. The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins. Cell. 1987 Apr 10;49(1):111–119. doi: 10.1016/0092-8674(87)90761-6. [DOI] [PubMed] [Google Scholar]
  2. Burnette W. N., Holladay L. A., Mitchell W. M. Physical and chemical properties of Moloney murine leukemia virus p30 protein: a major core structural component exhibiting high helicity and self-association. J Mol Biol. 1976 Oct 25;107(2):131–143. doi: 10.1016/s0022-2836(76)80022-8. [DOI] [PubMed] [Google Scholar]
  3. Crawford S., Goff S. P. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol. 1985 Mar;53(3):899–907. doi: 10.1128/jvi.53.3.899-907.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dittmar K. J., Moelling K. Biochemical properties of p15-associated protease in an avian RNA tumor virus. J Virol. 1978 Oct;28(1):106–118. doi: 10.1128/jvi.28.1.106-118.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hartsuck J. A., Tang J. The carboxylate ion in the active center of pepsin. J Biol Chem. 1972 Apr 25;247(8):2575–2580. [PubMed] [Google Scholar]
  6. Hiramatsu K., Nishida J., Naito A., Yoshikura H. Molecular cloning of the closed circular provirus of human T cell leukaemia virus type I: a new open reading frame in the gag-pol region. J Gen Virol. 1987 Jan;68(Pt 1):213–218. doi: 10.1099/0022-1317-68-1-213. [DOI] [PubMed] [Google Scholar]
  7. Hizi A., Henderson L. E., Copeland T. D., Sowder R. C., Hixson C. V., Oroszlan S. Characterization of mouse mammary tumor virus gag-pro gene products and the ribosomal frameshift site by protein sequencing. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7041–7045. doi: 10.1073/pnas.84.20.7041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Inoue J., Watanabe T., Sato M., Oda A., Toyoshima K., Yoshida M., Seiki M. Nucleotide sequence of the protease-coding region in an infectious DNA of simian retrovirus (STLV) of the HTLV-I family. Virology. 1986 Apr 15;150(1):187–195. doi: 10.1016/0042-6822(86)90278-3. [DOI] [PubMed] [Google Scholar]
  9. Jacks T., Townsley K., Varmus H. E., Majors J. Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4298–4302. doi: 10.1073/pnas.84.12.4298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacks T., Varmus H. E. Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science. 1985 Dec 13;230(4731):1237–1242. doi: 10.1126/science.2416054. [DOI] [PubMed] [Google Scholar]
  11. James M. N., Hsu I. N., Delbaere L. T. Mechanism of acid protease catalysis based on the crystal structure of penicillopepsin. Nature. 1977 Jun 30;267(5614):808–813. doi: 10.1038/267808a0. [DOI] [PubMed] [Google Scholar]
  12. Katoh I., Yasunaga T., Ikawa Y., Yoshinaka Y. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature. 1987 Oct 15;329(6140):654–656. doi: 10.1038/329654a0. [DOI] [PubMed] [Google Scholar]
  13. Katoh I., Yoshinaka Y., Rein A., Shibuya M., Odaka T., Oroszlan S. Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology. 1985 Sep;145(2):280–292. doi: 10.1016/0042-6822(85)90161-8. [DOI] [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Miller R. H. Proteolytic self-cleavage of hepatitis B virus core protein may generate serum e antigen. Science. 1987 May 8;236(4802):722–725. doi: 10.1126/science.3554507. [DOI] [PubMed] [Google Scholar]
  16. Misono K. S., Chang J. J., Inagami T. Amino acid sequence of mouse submaxillary gland renin. Proc Natl Acad Sci U S A. 1982 Aug;79(16):4858–4862. doi: 10.1073/pnas.79.16.4858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Misono K. S., Inagami T. Characterization of the active site of mouse submaxillary gland renin. Biochemistry. 1980 Jun 10;19(12):2616–2622. doi: 10.1021/bi00553a013. [DOI] [PubMed] [Google Scholar]
  18. Moore R., Dixon M., Smith R., Peters G., Dickson C. Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol. 1987 Feb;61(2):480–490. doi: 10.1128/jvi.61.2.480-490.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pearl L. H., Taylor W. R. A structural model for the retroviral proteases. Nature. 1987 Sep 24;329(6137):351–354. doi: 10.1038/329351a0. [DOI] [PubMed] [Google Scholar]
  20. Pinter A., Fleissner E. Structural studies of retroviruses: characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J Virol. 1979 Apr;30(1):157–165. doi: 10.1128/jvi.30.1.157-165.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rajagopalan T. G., Stein W. H., Moore S. The inactivation of pepsin by diazoacetylnorleucine methyl ester. J Biol Chem. 1966 Sep 25;241(18):4295–4297. [PubMed] [Google Scholar]
  22. Sauer R. T., Allen D. W., Niall H. D. Amino acid sequence of p15 from avian myeloblastosis virus complex. Biochemistry. 1981 Jun 23;20(13):3784–3791. doi: 10.1021/bi00516a018. [DOI] [PubMed] [Google Scholar]
  23. Sodek J., Hofmann T. Amino acid sequence around the active site aspartic acid in penicillopepsin. Can J Biochem. 1970 Sep;48(9):1014–1016. doi: 10.1139/o70-158. [DOI] [PubMed] [Google Scholar]
  24. Tang J., James M. N., Hsu I. N., Jenkins J. A., Blundell T. L. Structural evidence for gene duplication in the evolution of the acid proteases. Nature. 1978 Feb 16;271(5646):618–621. doi: 10.1038/271618a0. [DOI] [PubMed] [Google Scholar]
  25. Uckert W., Westermann P., Wunderlich V. Nearest neighbor relationships of major structural proteins within bovine leukemia virus particles. Virology. 1982 Sep;121(2):240–250. doi: 10.1016/0042-6822(82)90164-7. [DOI] [PubMed] [Google Scholar]
  26. Wray W., Boulikas T., Wray V. P., Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981 Nov 15;118(1):197–203. doi: 10.1016/0003-2697(81)90179-2. [DOI] [PubMed] [Google Scholar]
  27. Yasunaga T., Sagata N., Ikawa Y. Protease gene structure and env gene variability of the AIDS virus. FEBS Lett. 1986 Apr 21;199(2):145–150. doi: 10.1016/0014-5793(86)80468-9. [DOI] [PubMed] [Google Scholar]
  28. Yoshinaka Y., Katoh I., Copeland T. D., Oroszlan S. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc Natl Acad Sci U S A. 1985 Mar;82(6):1618–1622. doi: 10.1073/pnas.82.6.1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yoshinaka Y., Katoh I., Copeland T. D., Oroszlan S. Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease. J Virol. 1985 Sep;55(3):870–873. doi: 10.1128/jvi.55.3.870-873.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yoshinaka Y., Katoh I., Copeland T. D., Smythers G. W., Oroszlan S. Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins. J Virol. 1986 Mar;57(3):826–832. doi: 10.1128/jvi.57.3.826-832.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yoshinaka Y., Katoh I., Luftig R. B. Murine retrovirus Pr65gag forms a 130K dimer in the absence of disulfide reducing agents. Virology. 1984 Jul 30;136(2):274–281. doi: 10.1016/0042-6822(84)90164-8. [DOI] [PubMed] [Google Scholar]
  32. Yoshinaka Y., Luftig R. B. Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3446–3450. doi: 10.1073/pnas.74.8.3446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yoshinaka Y., Luftig R. B. Physicochemical characterization and specificity of the murine leukaemia virus Pr65gag proteolytic factor. J Gen Virol. 1980 Jun;48(Pt 2):329–340. doi: 10.1099/0022-1317-48-2-329. [DOI] [PubMed] [Google Scholar]
  34. Yoshinaka Y., Luftig R. B. Properties of a P70 proteolytic factor of murine leukemia viruses. Cell. 1977 Nov;12(3):709–719. doi: 10.1016/0092-8674(77)90271-9. [DOI] [PubMed] [Google Scholar]
  35. Yoshinaka Y., Luftig R. B. p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity. Virology. 1982 Apr 30;118(2):380–388. doi: 10.1016/0042-6822(82)90357-9. [DOI] [PubMed] [Google Scholar]
  36. von der Helm K. Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15. Proc Natl Acad Sci U S A. 1977 Mar;74(3):911–915. doi: 10.1073/pnas.74.3.911. [DOI] [PMC free article] [PubMed] [Google Scholar]